Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday newspaper round-up: Wilko, John Lewis, ARM...

(Sharecast News) - Administrators to discount chain Wilko have won the backing of creditors for a rescue deal led by HMV tycoon Doug Putman that could save about 8,000 jobs. PwC is understood to have secured support from the Pension Protection Fund, an industry-backed lifeboat, as well as other creditors, including major landlords and suppliers, for the deal. - The Sunday Times EY, the auditor of collapsed retail chain Wilko, is facing a backlash for its oversight of the group after signing off its accounts despite the firm having warned that it did not have enough funds to cope with a sharp drop in sales. [...] The risk of insolvency appears to have been flagged as long ago as January last year when the firm was putting the finishing touches to its most recent set of annual accounts, for the year to 29 January, 2022. - Mail on Sunday

John Lewis faces "extreme challenges" in making a paper profit on its flagship housing scheme, its advisers have warned. A scheme to build more than 400 flats above a Waitrose in West Ealing risks costing significantly more to build than it is worth on paper. The project threatens to deliver a negative return of £57m, planning documents show. The official early analysis, commissioned by John Lewis Partnership, raises fresh questions about the retailer's plans to expand into property under chairman Dame Sharon White. - The Sunday Telegraph

British chip designer Arm is seeking a valuation of between $50 billion (£40 billion) and $55 billion when it floats in the US this month, a significant cut to the $64 billion figure it achieved in a deal last month. The downgrade appears to be a big climbdown for its owner, the Japanese investment giant SoftBank, which acquired the 25 per cent of Arm it did not already control from its own Vision Fund for $16.1 billion in August. The deal implied a value of $64 billion. - The Sunday Times

Britain faces the biggest jump in age-related healthcare spending in Europe as a result of a rapidly expanding NHS and an increasingly elderly population. Spending on healthcare for the elderly is on course to rise by just under 8pc of gross domestic product (GDP) over the next 50 years, official projections show - or around £200bn in today's money. This compares with a predicted rise of less than 1pc of GDP over the same period in Germany and around 2pc in France, where health insurance is mandatory. - The Sunday Telegraph

Chancellor Jeremy Hunt has insisted that his plan to halve inflation is "working" despite further expected interest rate hikes and rising energy bills set to inflict more pain on households. [...] Mr Hunt said he knew family budgets were still stretched, but he insisted "we are on track to halve inflation this year and by sticking to our plan we will ease the pressure on families and businesses alike". - The Independent

The government is in advanced talks with the country's largest steel producer, Tata Steel, over a £500m package to secure its long-term future in the UK, according to reports. [...] Under the deal, Tata Steel would also be required to commit to building electric arc furnaces to reduce carbon emissions. The production process, which is less labour-intensive than current blast furnaces, could result in the loss of thousands of jobs. - The Guardian

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Höfner, Sotheby's, Christie's
(Sharecast News) - Ministers and senior MPs have warned that the UK's agreements with Donald Trump are "built on sand" after the Guardian established that the deal to avoid drug tariffs has no underlying text beyond limited headline terms. The "milestone" US-UK deal announced this month on pharmaceuticals, which will mean the NHS pays more for medicines in exchange for a promise of zero tariffs on the industry, still lacks a legal footing beyond top lines contained in two government press releases. - Guardian
Wednesday newspaper round-up: Grangemouth ethylene plant, Warner Bros, ChatGPT
(Sharecast News) - Jim Ratcliffe's chemicals company Ineos has been granted £120m of government funding to help save the UK's last ethylene plant at Grangemouth, in a deal expected to protect more than 500 jobs. The investment in the Scottish plant was necessary to preserve a vital part of the country's chemicals infrastructure, the UK government said. The ethylene produced there was essential for medical-grade plastics production, water treatment and in aerospace and car-building, it added. - Guardian
Tuesday newspaper round-up: Nissan, Morrisons, Ford
(Sharecast News) - Nissan has started the production of its latest electric car in Sunderland, a crucial step in the UK automotive industry's transition away from petrol and diesel. The Japanese manufacturer will launch the third generation of the Leaf on Tuesday, which was the first mass-market battery electric car to be built in the UK. Nissan has made 282,704 Leaf models at the north-east England plant so far. - Guardian
Monday newspaper round-up: Cryptocurrencies, jobs downturn, Cycle Pharma
(Sharecast News) - Cryptocurrencies will be regulated in a similar way to other financial products under legislation coming into force in 2027. The Treasury is drawing up rules that will require crypto companies to meet a set of standards overseen by the Financial Conduct Authority (FCA). Ministers have sought to overhaul the crypto market, which has ballooned in popularity as a way of investing money and making payments. Cryptocurrencies have not been subject to the same regulation as traditional financial products such as stocks and shares, which means that in many cases consumers do not enjoy the same level of protection. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.